Beaumont RCSI Cancer Centre

Education and Training

Education and TrainingNavigation

Beaumont RCSI Cancer Centre endeavours to provide a professional caring environment for staff to work in, building on prior skills, experience and knowledge, to help staff to develop as a practitioners.

 

 

  • Cancer Nurse Education

    We encourage and support the advancement of cancer practice through participation in continuing professional development, empowering nurses to play an active, evidenced based role in supporting patients and their carers through their journey with us.

    A number of National University of Ireland (NUI) accredited third level programmes, in partnership with RCSI School of Nursing, are facilitated by an Oncology Educator Coordinator based in Beaumont Hospital Centre of Education. Central to these courses are contributions from a wide variety of multi-disciplinary healthcare professionals involved in the provision of cancer services within and outside of Beaumont Hospital. Courses are facilitated using a blended learning approach, with study days delivered both in the classroom setting and online

    Beaumont RCSI Cancer Centre also provides hospital developed Cancer Care courses, with Nursing and Midwifery Board of Ireland (NMBI) Category 1 approval, for nurses new to this speciality.

    A nurse must complete a theoretical and clinical evaluation component for some of these courses, including supervised practice for systemic anti-cancer therapy (SACT) practice.

    Post graduate courses available in conjunction with RCSI: Level 9 National Framework Qualification

    • Postgraduate Diploma in Cancer Nursing
    • Postgraduate Diploma in Nursing
    • Postgraduate Certificate in Nursing
    • Breast Disease Stand Alone Module
    • Colorectal Disease Stand Alone Module
    • Neuro-Oncology Stand Alone Module

    Post graduate courses available with NMBI Category 1 approval

    • One day Introductory Course in Cancer Care
    • Beaumont Hospital Specialist Practice Programme in Oncology/Haematology Nursing (Cancer Care)

    Topics covered in the classroom setting for most courses include:

    • Principles of SACTs (Chemotherapy, Targeted Therapies, Immunotherapy, Hormonal Therapy) including cell biology, cellular kinetics of   normal and malignant cells, goals of treatment, classifications and mechanism of action, drug selection and treatment regimes
    • Toxicities, side effects and adverse events associated with SACTs
    • Principles and requirements for safe handling of SACT’s and related waste
    • Principles of safe SACT administration including hypersensitivity reaction and extravasation
    • Assessment of the patient receiving cancer treatment and their family including Telephone Triage
    • Oncological Emergencies
    • Psycho/social oncology care
    • Cancer prevention and screening
    • Survivorship
    • Selection, care and maintenance of vascular access devices (CVADs)
    • Outline of the most common cancers
    • Staging of cancer and tumour markers
    • Delivering Bad News Well in Cancer Care Workshop

     

    For further information contact our Oncology Education Coordinators:

    Aine Byrne

    Tel: 01 8528794

    Email: ainebyrne@beaumont.ie

     

     

     

  • 11th All Ireland Lung Cancer Conference April 2024

    The 11th All Ireland Lung Cancer Conference took place in Barberstown Castle on April 12th and 13th 2024. You can view the presentations by clicking on the image.

    Conference Agenda

    Friday April 12th 2024 All Ireland Lung Cancer Conference Sessions

    17:05 – 18:05: Genomic Testing and Treatment in NSCLC: Cases + Controversies
    Moderators: Deirdre Kelly, Mater Misericordiae Hospital, Greg Korpanty, Limerick Regional Hospital
    Current and Future Standards in Tissue-Testing and Molecular Profiling for NSCLC
    Dr Reiltin Werner, Chief Medical Scientist, Molecular Pathology, CUH, Prof Louise Burke Dept. of Pathology, CUH/UCC
    Liquid Biopsies: Current Use, and Future Applications
    Prof Natasha Leighl, Princess Margaret Hospital, Toronto, Canada
    Targeted Therapy for EGFR, ALK + ROS1: Raising the bar.
    Dr Jordi Remon, Consultant Medical Oncologist, Medicine Department Gustave Roussy, Villejuif, France
    Targeted Therapy for rare oncogenic drivers: RET, MET, BRAF
    Dr Niamh Coleman, Consultant Medical Oncologist, SJH

     

    18.40 -19.30

    Molecular Tumour Board led Case Discussion Chris Coleman Oncology SPR Beaumont and Panel Discussion. Lead: Dearbhaile Collins, Panel: Natasha Leighl, Jordi Remon, Niamh Coleman
    A Career as a Clinical Investigator in Oncology
    Prof. Natasha Leighl, Princess Margaret Hospital, Toronto, Canada
    Prof. Julie Brahmer, Professor of Oncology and Division Director, Johns Hopkins University

    Saturday April 13th Conference Sessions

    Early Stage NSCLC: Cases + Controversies (15 mins each to incl of 5 mins Q&A)  9.00-12.00

    Moderators: Jane Sui, Consultant Medical Oncologist, Mater Private Hospital
    Gerard Walls, Consultant Clinical Oncologist, Belfast University Trust

    Perioperative Therapy for Resectable NSCLC
    Dr Patrick Forde, Associate Professor of Oncology, John Hopkins University
    Surgery for Early Stage NSCLC: New Tools + Techniques
    Mr Ronan Ryan, Consultant Cardiothoracic Surgeon, St James’s Hospital
    SABR in Early Stage NSCLC: Pro’s, Cons and Future Directions
    Dr Cathryn Crockett, Consultant in Radiation Oncology, Belfast Health and Social Care Trust
    Fellow-led Case Presentation and Panel Discussion. 
    Dr Laurenn Rabbitt Clinical Dilemma of Stage III NSCLC
    10:20-12:20 Locally Advanced and Oligometastatic NSCLC: Cases + Controversies

    Moderators: Ronan McDermott, Consultant Radiation Oncologist, Galway University Hospital
    Emer Hanrahan, St. Vincent’s University Hospital

    Integrating Systemic Therapy in Stage III NSCLC: PACIFIC and beyond. Dr Jarushka Naidoo, Professor of Oncology, Beaumont RCSI Cancer Centre

    Radiation Therapy for Locally Advanced and Oligometastatic NSCLC
    Prof Gerry Hanna, Consultant in Clinical Oncology, Chair of Division, Cancer and Specialist Medicine,
    Belfast Health and Social Care Trust; Honorary Professor, Patrick G Johnstone Centre for Cancer
    Research, Queen’s University Belfast
    Advances in the Treatment of Oligometastatic NSCLC
    Dr Lizza Hendriks, Associate Professor, Maastricht University, The Netherlands
    A Career in Europe as a clinical trialist and working with cooperative groups.
    Dr Lizza Hendriks, Associate Professor, Maastricht University, The Netherlands
    11:20-12:30 Special Populations in Thoracic Oncology
    Moderators: Annemarie Baird, St. James’s Hospital/Trinity College Dublin
    Sebastian Trainor, Consultant Medical Oncologist, Tallaght University Hospital
    Advances in Small Cell Lung Cancer: New Standards of Care.
    Dr Sinead Noonan, Consultant Medical Oncologist, CUH
    Advances in Mesothelioma: New Standards of Care
    Prof Alessandra Curioni-Fontecedro, Professor of Oncology, Fribourg Hospital, Switzerland
    Advances in Patient Advocacy for Lung Cancer
    Seamus Cotter, Chairperson of the Irish Lung Cancer Community
    A Career in the lab and the clinic
    Professor Alessandra Curioni-Fontecedro, Professor of Oncology, Fribourg Hospital, Switzerland
    The Story of Immunotherapy in NSCLC: The beginning, the middle, the future
    Professor Julie Brahmer, Professor of Oncology and Division Director, Johns Hopkins University
  • Beaumont RCSI Cancer Conference May 2024 - Cancer Care for All, Understanding Populations

    The Beaumont RCSI Cancer Conference will take place on May 16th 2024 in the Smurfit Education and Resource Centre at Beaumont Hospital.

    This year the focus is on understanding population for better outcomes and speakers include:

    Professor Willie Hamilton  

    Professor Ed Greg 

    Professor Mark Lawler

    Professor Jarushka Naidoo

    Ms Siobhan Gaynor

    More details to follow